Literature DB >> 6660860

Cefoxitin inactivation by Bacteroides fragilis.

G J Cuchural, F P Tally, N V Jacobus, P K Marsh, J W Mayhew.   

Abstract

We have surveyed the susceptibility of 1,575 clinical isolates of the Bacteroides fragilis group of organisms to cefoxitin and eight other antimicrobial agents. Eleven isolates, 0.7% of the total, were highly cefoxitin resistant and had minimum inhibitory concentrations of greater than or equal to 64 micrograms/ml. These isolates were also resistant to other beta-lactam antibiotics. Of 11 isolates, 4 were able to inactivate cefoxitin in broth cultures, as measured by microbiological and high-pressure liquid chromatography assays. Two distinct patterns of cefoxitin breakdown products were detected by high-pressure liquid chromatography analysis. The beta-lactamase inhibitors clavulanic acid and sulbactam failed to show synergism with cefoxitin. These data demonstrate that members of the B. fragilis group have acquired a novel resistance mechanism enabling them to inactivate cefoxitin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660860      PMCID: PMC185411          DOI: 10.1128/AAC.24.6.936

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  beta-Lactamases of subspecies of Bacteroides fragilis.

Authors:  T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

3.  Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.

Authors:  K Dornbusch; B Olsson-Lijequist; C E Nord
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

4.  Inactivation of penicillin G during experimental infection with Bacteroides fragilis.

Authors:  J P O'Keefe; F P Tally; M Barza; S L Gorbach
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

5.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

6.  Inactivation of cephalosporins by Bacteroides.

Authors:  F P Tally; J P O'Keefe; N M Sullivan; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

7.  A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis.

Authors:  F P Tally; K McGowan; J M Kellum; S L Gorbach; T F O'Donnell
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969

8.  In vitro activity of LY127935.

Authors:  M Barza; F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

9.  Antibiotic levels in infected and sterile subcutaneous abscesses in mice.

Authors:  K A Joiner; B R Lowe; J L Dzink; J G Bartlett
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

10.  Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.

Authors:  G Darland; J Birnbaum
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  26 in total

1.  In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.

Authors:  K Lee; I H Jang; Y J Kim; Y Chong
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

Authors:  P C Appelbaum; A Philippon; M R Jacobs; S K Spangler; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 3.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

4.  Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Authors:  G J Cuchural; F P Tally; N V Jacobus; T Cleary; S M Finegold; G Hill; P Iannini; J P O'Keefe; C Pierson
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

5.  Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II.

Authors:  J S Thompson; M H Malamy
Journal:  J Bacteriol       Date:  1990-05       Impact factor: 3.490

6.  Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.

Authors:  R J Zabransky; R J Birk; T A Kurzynski; K L Toohey
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

Review 7.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 8.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

9.  Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.

Authors:  P Mastrantonio; P Spigaglia; A Sebastianelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

10.  Belgian Collaborative Study of the in-vitro susceptibility of the Bacteroides fragilis group. A Belgian Collaborative Study Group.

Authors: 
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.